Guerbet SA (EPA:GBT)
13.12
+0.26 (2.02%)
Sep 26, 2025, 5:35 PM CET
Guerbet Revenue
Guerbet had revenue of 394.72M EUR in the half year ending June 30, 2025, with 3.93% growth. This brings the company's revenue in the last twelve months to 820.92M, down -2.36% year-over-year. In the year 2024, Guerbet had annual revenue of 851.12M with 6.97% growth.
Revenue (ttm)
820.92M
Revenue Growth
-2.36%
P/S Ratio
0.20
Revenue / Employee
288.85K
Employees
2,905
Market Cap
165.36M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 851.12M | 55.46M | 6.97% |
Dec 31, 2023 | 795.65M | 26.16M | 3.40% |
Dec 31, 2022 | 769.50M | 33.59M | 4.56% |
Dec 31, 2021 | 735.91M | 19.24M | 2.68% |
Dec 31, 2020 | 716.67M | -102.33M | -12.49% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 4.12B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
ABIVAX Société Anonyme | 6.02M |
Virbac | 1.43B |